Press Release

OUTCOME OF THE OPTION OFFER OF THE SHARES SUBJECT TO WITHDRAWAL

Viareggio, 10 July 2023 - Talea Group S.p.A., a company listed on the Euronext Growth Milan market of the Italian Stock Exchange, resulting from the rebranding of Farmaè S.p.A. and leader in the e-retailing of products for personal health and wellbeing as well as in media and digital transformation services for businesses (the "Company") - announces that on 6 July 2012, the option offer period pursuant to article 2437-quater of the Italian Civil Code (the "Option Offer Period") ended; this offer concerned the 281,077 shares of the Company (the "Shares") for which the right of withdrawal was exercised following the resolution adopted by the Shareholders' Meeting in extraordinary session on 28 April 2023 concerning, inter alia, the amendments to the Articles of Association relating to the extension of the corporate purpose.

At the end of the Option Offer Period, as a result of the exercise of the option right, no. 214,244 Shares, representing 76.22% of the Shares, were assigned for a total consideration of Euro 2,508,797.24. No shareholder exercised the pre-emption right pursuant to Article 2437-quater, paragraph 3 of the Italian Civil Code.

The shareholders RIAC Holding S.r.l. (a vehicle controlled by Chairman and CEO Riccardo Iacometti) and MDF Holding S.r.l. (a vehicle controlled by director Marco Di Filippo) exercised their pre-emptive right to purchase the Shares held by them, thus confirming their full commitment to the strategic project started with the rebranding of the Company into Talea Group and the expansion of the corporate purpose.

Pursuant to Article 2437-quater, paragraph 4 of the Italian Civil Code, the Company shall offer to third parties the no. 66,858 Shares remaining unexercised, in order to end this activity by and no later than 31 October 2023 (the "Third Party Placement"). Upon completion, the Company will disclose the number of Shares left over from the Third-Party Placement, which, pursuant to article 2437-quater, paragraph 5 of the Italian Civil Code, will be redeemed and bought by the Company itself.

Thus, the payment of the redemption value of the Shares to each shareholder of the Company exercising the right of withdrawal, as well as the transfer of the Shares allotted within the Option Offer Period, the Third-Party Placement and, possibly, the purchase by the Company, will be carried out through the relevant intermediaries.

The terms and conditions of transfer (and payment) of the Shares allotted in the framework of the Option Offer Period, of the Third-Party Placement and, possibly, of the purchase by the Company, as well as the date of the aforesaid transfer (and payment) will be announced by means of specific press releases circulated through the SDIR System - "eMarket" and published on the Company's website at www.taleagroupspa.com, Section "Investor Relations/Press releases".

***

This press release is available in the Investor Relations section of the Company's website www.taleagroupspa.com.

***

Talea Group S.p.A, a company listed on the Euronext Growth Milan market of the Italian Stock Exchange and resulting from the rebranding of Farmaè S.p.A, is one of the leading digital groups in Europe in the Health, Wellness and Beauty multichannel macro-sector and in media and digital transformation services for businesses. Talea Group S.p.A. operates with a business model based on two revenue- generating areas: the Consumers Area, dedicated to e-retaling in which the brands Farmaè, Amicafarmacia, Farmaeurope, Sanort and Beautyè currently operate, and the Industrial Area dedicated to media services and digital transformation with Talea Media and Valnan Communications. The Group - which today employs more than 240 professionals - places People and Companies at the centre of its

values and actions in order to satisfy their needs and desires, and bases its identity on digital culture and the ability to evolve business models and generate growth within its relevant markets through innovative and sustainable solutions.

For further information:

Euronext Growth Advisor

Specialist

Alantra Capital Markets

MIT SIM S.p.A.

+39 02 63671601

+39 02 30561 276

Stefano Bellavita

trading-desk@mitsim.it

stefano.bellavita@alantra.com

Investor Relation

Media Relation

Talea Group

SEC Newgate - 02.6249991 - talea@secrp.com

Investor Relations Officer

Daniele Pinosa - 335 7233872 - daniele.pnosa@secnewgate.it

Alberto Maglione

Fabio Santilio - 339 8446521 - fabio.santilio@secnewgate.it

+39 0584 1660552

Giorgia Cococcioni - 366 2363331 - giorgia.cococcioni@secnewgate.it

ir@farmaegroup.it

CDR Communication

IR Advisor

Vincenza Colucci

Tel. +39 335 6909547

vincenza.colucci@cdr-communication.it

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

FARMAè S.p.A. published this content on 10 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 July 2023 15:25:07 UTC.